<DOC>
	<DOCNO>NCT01353183</DOCNO>
	<brief_summary>The aim project develop original biomarker Parkinson 's disease ( PD ) parkinsonian syndrome ( multiple system atrophy progressive supranuclear palsy ) base upon detection pathological alpha-synuclein specie routine colonoscopic biopsy .</brief_summary>
	<brief_title>Analysis Enteric Nervous System Using Colonic Biopsies</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Atrophy</mesh_term>
	<mesh_term>Multiple System Atrophy</mesh_term>
	<mesh_term>Shy-Drager Syndrome</mesh_term>
	<mesh_term>Supranuclear Palsy , Progressive</mesh_term>
	<criteria>Patients Patients age 5080 year old , gender Parkinson 's disease patient Multiple system atrophy patient Progressive supranuclear palsy patient Controls : patient risk colic cancer colonoscopy require Patients sign informed consent Controls Patients age 50 80 yearold rectosigmoidoscopy colonoscopy require colorectal screening Patients sign informed consent Health care beneficiary Patients Colonic disorder ( except noncomplicated diverticular disease ) Other neurological disorder parkinsonism Patients treat either platelet antiaggregants , anticoagulant know coagulation disorder Patients cognitive impairment preclude understand informed consent Patients place legal guardianship Controls Neurodegenerative disorder Parkinson 's disease , Alzheimer 's disease dementia , amyotrophic lateral sclerosis ... Functional bowel disorder irritable bowel syndrome Patients cognitive impairment preclude understand informed consent</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>biopsy , enteric nervous system , biomarker</keyword>
</DOC>